FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000414307> ?p ?o ?g. }

• W2000414307 endingPage "1083" @default.
• W2000414307 startingPage "1076" @default.
• W2000414307 abstract "ObjectiveIncreased levels of glutamate, the main excitatory neurotransmitter, are found in the synovial fluid of osteoarthritis (OA) patients. Our aim was to study glutamate signaling in chondrocytes, focusing on the composition, pharmacology, and functional role of N-methyl-d-aspartate (NMDA) glutamate receptors.MethodsWe used the human chondrocyte cell line SW1353 and, in parallel, primary rat articular chondrocytes. Glutamate release and uptake were measured by fluorimetric and radiometric methods, respectively. Gene expression was analyzed by quantitative polymerase chain reaction. NMDA receptor pharmacology was studied in binding experiments with [3H]MK-801, a specific NMDA receptor antagonist. RNA interference was used to knock-down the expression of NR1, a subunit of NMDA receptors.ResultsGlutamate release, sodium- and calcium-dependent glutamate uptake, and the expression of a glutamate transporter were observed in chondrocytes. NR2D was the most abundant NMDA receptor subunit in these cells. Consistent with this observation, the binding affinity of [3H]MK-801 was much lower in chondrocytes than in rat brain membranes (mean Kd values of 700 and 2.6 nM, respectively). NR1 knock-down, as well as NMDA receptor blockade with MK-801, reduced chondrocyte proliferation. Interleukin (IL)-1β significantly altered glutamate release and uptake (about 90% increase and 50% decrease, respectively, in SW1353 cells). Moreover, IL-1β induced the gene expression of cytokines and enzymes involved in cartilage degradation, and MK-801 significantly inhibited this response.ConclusionsOur findings suggest that chondrocytes express a self-sufficient machinery for glutamate signaling, including a peripheral NMDA receptor with unique properties. This receptor may have a role in the inflammatory process associated with cartilage degradation, thus emerging as a potential pharmacological target in OA. Increased levels of glutamate, the main excitatory neurotransmitter, are found in the synovial fluid of osteoarthritis (OA) patients. Our aim was to study glutamate signaling in chondrocytes, focusing on the composition, pharmacology, and functional role of N-methyl-d-aspartate (NMDA) glutamate receptors. We used the human chondrocyte cell line SW1353 and, in parallel, primary rat articular chondrocytes. Glutamate release and uptake were measured by fluorimetric and radiometric methods, respectively. Gene expression was analyzed by quantitative polymerase chain reaction. NMDA receptor pharmacology was studied in binding experiments with [3H]MK-801, a specific NMDA receptor antagonist. RNA interference was used to knock-down the expression of NR1, a subunit of NMDA receptors. Glutamate release, sodium- and calcium-dependent glutamate uptake, and the expression of a glutamate transporter were observed in chondrocytes. NR2D was the most abundant NMDA receptor subunit in these cells. Consistent with this observation, the binding affinity of [3H]MK-801 was much lower in chondrocytes than in rat brain membranes (mean Kd values of 700 and 2.6 nM, respectively). NR1 knock-down, as well as NMDA receptor blockade with MK-801, reduced chondrocyte proliferation. Interleukin (IL)-1β significantly altered glutamate release and uptake (about 90% increase and 50% decrease, respectively, in SW1353 cells). Moreover, IL-1β induced the gene expression of cytokines and enzymes involved in cartilage degradation, and MK-801 significantly inhibited this response. Our findings suggest that chondrocytes express a self-sufficient machinery for glutamate signaling, including a peripheral NMDA receptor with unique properties. This receptor may have a role in the inflammatory process associated with cartilage degradation, thus emerging as a potential pharmacological target in OA." @default.
• W2000414307 created "2016-06-24" @default.
• W2000414307 creator A5008187163 @default.
• W2000414307 creator A5010218371 @default.
• W2000414307 creator A5020441048 @default.
• W2000414307 creator A5063288145 @default.
• W2000414307 creator A5066549404 @default.
• W2000414307 creator A5087089921 @default.
• W2000414307 date "2009-08-01" @default.
• W2000414307 modified "2023-10-14" @default.
• W2000414307 title "Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression" @default.
• W2000414307 cites W1519351707 @default.
• W2000414307 cites W1579591510 @default.
• W2000414307 cites W1594111906 @default.
• W2000414307 cites W1600539804 @default.
• W2000414307 cites W1868834139 @default.
• W2000414307 cites W1979467473 @default.
• W2000414307 cites W1994259993 @default.
• W2000414307 cites W1997448160 @default.
• W2000414307 cites W1998547126 @default.
• W2000414307 cites W2007826606 @default.
• W2000414307 cites W2009524387 @default.
• W2000414307 cites W2011654786 @default.
• W2000414307 cites W2013607742 @default.
• W2000414307 cites W2013678742 @default.
• W2000414307 cites W2022671065 @default.
• W2000414307 cites W2035339470 @default.
• W2000414307 cites W2037981984 @default.
• W2000414307 cites W2038083756 @default.
• W2000414307 cites W2044146387 @default.
• W2000414307 cites W2044554277 @default.
• W2000414307 cites W2048152070 @default.
• W2000414307 cites W2048976632 @default.
• W2000414307 cites W2050707083 @default.
• W2000414307 cites W2056374964 @default.
• W2000414307 cites W2060830991 @default.
• W2000414307 cites W2063355095 @default.
• W2000414307 cites W2065169750 @default.
• W2000414307 cites W2072086528 @default.
• W2000414307 cites W2089939109 @default.
• W2000414307 cites W2092916498 @default.
• W2000414307 cites W2093573816 @default.
• W2000414307 cites W2093995681 @default.
• W2000414307 cites W2106411663 @default.
• W2000414307 cites W2132493492 @default.
• W2000414307 cites W2157480537 @default.
• W2000414307 cites W2169132943 @default.
• W2000414307 doi "https://doi.org/10.1016/j.joca.2009.02.002" @default.
• W2000414307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19233337" @default.
• W2000414307 hasPublicationYear "2009" @default.
• W2000414307 type Work @default.
• W2000414307 sameAs 2000414307 @default.
• W2000414307 citedByCount "44" @default.
• W2000414307 countsByYear W20004143072012 @default.
• W2000414307 countsByYear W20004143072013 @default.
• W2000414307 countsByYear W20004143072014 @default.
• W2000414307 countsByYear W20004143072015 @default.
• W2000414307 countsByYear W20004143072016 @default.
• W2000414307 countsByYear W20004143072018 @default.
• W2000414307 countsByYear W20004143072019 @default.
• W2000414307 countsByYear W20004143072020 @default.
• W2000414307 countsByYear W20004143072021 @default.
• W2000414307 countsByYear W20004143072022 @default.
• W2000414307 countsByYear W20004143072023 @default.
• W2000414307 crossrefType "journal-article" @default.
• W2000414307 hasAuthorship W2000414307A5008187163 @default.
• W2000414307 hasAuthorship W2000414307A5010218371 @default.
• W2000414307 hasAuthorship W2000414307A5020441048 @default.
• W2000414307 hasAuthorship W2000414307A5063288145 @default.
• W2000414307 hasAuthorship W2000414307A5066549404 @default.
• W2000414307 hasAuthorship W2000414307A5087089921 @default.
• W2000414307 hasBestOaLocation W20004143071 @default.
• W2000414307 hasConcept C170493617 @default.
• W2000414307 hasConcept C185592680 @default.
• W2000414307 hasConcept C202751555 @default.
• W2000414307 hasConcept C2777836312 @default.
• W2000414307 hasConcept C2781403057 @default.
• W2000414307 hasConcept C55493867 @default.
• W2000414307 hasConcept C61174792 @default.
• W2000414307 hasConcept C67018056 @default.
• W2000414307 hasConcept C86803240 @default.
• W2000414307 hasConcept C95444343 @default.
• W2000414307 hasConcept C98274493 @default.
• W2000414307 hasConceptScore W2000414307C170493617 @default.
• W2000414307 hasConceptScore W2000414307C185592680 @default.
• W2000414307 hasConceptScore W2000414307C202751555 @default.
• W2000414307 hasConceptScore W2000414307C2777836312 @default.
• W2000414307 hasConceptScore W2000414307C2781403057 @default.
• W2000414307 hasConceptScore W2000414307C55493867 @default.
• W2000414307 hasConceptScore W2000414307C61174792 @default.
• W2000414307 hasConceptScore W2000414307C67018056 @default.
• W2000414307 hasConceptScore W2000414307C86803240 @default.
• W2000414307 hasConceptScore W2000414307C95444343 @default.
• W2000414307 hasConceptScore W2000414307C98274493 @default.
• W2000414307 hasIssue "8" @default.
• W2000414307 hasLocation W20004143071 @default.
• W2000414307 hasLocation W20004143072 @default.
• W2000414307 hasOpenAccess W2000414307 @default.

• next